Equillium, Inc. - stock earnings
EQ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.7 million USD | 8.9 million USD |
| 2023Q2 | -3.3 million USD | 9.1 million USD |
| 2023Q1 | -3.9 million USD | 8.9 million USD |
| 2022Q4 | 3.8 million USD | 15.8 million USD |
| 2022Q3 | -14.1 million USD | ? USD |
| 2022Q2 | -14.7 million USD | ? USD |
| 2022Q1 | -60.5 million USD | ? USD |
| 2021Q4 | -10.6 million USD | ? USD |
| 2021Q3 | -10.3 million USD | ? USD |
| 2021Q2 | -9.2 million USD | ? USD |
| 2021Q1 | -9.0 million USD | ? USD |
| 2020Q4 | -8.9 million USD | ? USD |
| 2020Q3 | -6.6 million USD | ? USD |
| 2020Q2 | -6.5 million USD | ? USD |
| 2020Q1 | -7.8 million USD | ? USD |
| 2019Q4 | -7.6 million USD | ? USD |
| 2019Q3 | -6.0 million USD | ? USD |
| 2019Q2 | -6.1 million USD | ? USD |
| 2019Q1 | -6.0 million USD | ? USD |
| 2018Q4 | -5.0 million USD | ? USD |
| 2018Q3 | -4.9 million USD | ? USD |
| 2018Q2 | -1.8 million USD | ? USD |
| 2018Q1 | -1.6 million USD | ? USD |
| 2017Q4 | -1.1 million USD | ? USD |
| 2017Q3 | -141025 USD | ? USD |
| 2017Q2 | -1.0 million USD | ? USD |
EQ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.2 million USD | 42.6 million USD |
| 2022 | -107.7 million USD | 15.8 million USD |
| 2021 | -39.0 million USD | ? USD |
| 2020 | -29.8 million USD | ? USD |
| 2019 | -25.6 million USD | ? USD |
| 2018 | -13.3 million USD | ? USD |
| 2017 | -2.3 million USD | ? USD |
EQ
Price: $1.71
52 week price:
Earnings Per Share: -0.38 USD
P/E Ratio: -7.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 25774
Market Capitalization: 65.2 million